A randomised controlled trial to evaluate the efficacy of vonoprazan for artificial ulcer healing after gastric endoscopic submucosal dissectio
Not Applicable
- Conditions
- Gastric ulcer
- Registration Number
- JPRN-UMIN000019835
- Lead Sponsor
- ational Center for Global Health and Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with 1)the history of surgery for upper GI 2)concomitant administration of anticoagulants 3)concomitant administration of PPI 4)the history of radiotherapy or chemotherapy within 3 months 5)gastric hyperacidity such as Zollinger-Ellison syndorome 6)allergy to PPI or rebamipide
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cure rates of gastric ulcer at 4 weeks after treatment
- Secondary Outcome Measures
Name Time Method Cure rates of gastric ulcer at 8 weeks after treatment, reduction rates of gastric ulcer at 4 and 8 weeks after treatment, incidence rate of delayed bleeding